ChemicalBook > CAS DataBase List > GSK2110183B

GSK2110183B

Product Name
GSK2110183B
CAS No.
1047645-82-8
Chemical Name
GSK2110183B
Synonyms
GSK2110183B;GSK 2110183B;GSK-2110183B;Afuresertib HCl;GSK2110183 hydrochloride;GSK-2110183 hydrochloride;GSK 2110183 hydrochloride;Afuresertib (hydrochloride);Afuresertib HCl (GSK2110183);Afuresertib hydrochloride GSK2110183
CBNumber
CB02667591
Molecular Formula
C18H18Cl3FN4OS
Formula Weight
463.78
MOL File
1047645-82-8.mol
More
Less

GSK2110183B Property

storage temp. 
Store at -20°C, protect from light, stored under nitrogen
solubility 
DMSO:65.0(Max Conc. mg/mL);140.15(Max Conc. mM)
DMF:50.0(Max Conc. mg/mL);107.81(Max Conc. mM)
Ethanol:50.0(Max Conc. mg/mL);107.81(Max Conc. mM)
Ethanol:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);1.08(Max Conc. mM)
form 
A crystalline solid
color 
Yellow to brown
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P321Specific treatment (see … on this label).

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
17988
Product name
Afuresertib (hydrochloride)
Purity
≥98%
Packaging
1mg
Price
$40
Updated
2024/03/01
Cayman Chemical
Product number
17988
Product name
Afuresertib (hydrochloride)
Purity
≥98%
Packaging
5mg
Price
$138
Updated
2024/03/01
Cayman Chemical
Product number
17988
Product name
Afuresertib (hydrochloride)
Purity
≥98%
Packaging
10mg
Price
$254
Updated
2024/03/01
Cayman Chemical
Product number
17988
Product name
Afuresertib (hydrochloride)
Packaging
25mg
Price
$583
Updated
2024/03/01
ChemScene
Product number
CS-3385
Product name
Afuresertib(hydrochloride)
Purity
98.02%
Packaging
100mg
Price
$564
Updated
2021/12/16
More
Less

GSK2110183B Chemical Properties,Usage,Production

Uses

Afuresertib is a selective, orally bioavailable inhibitor of Akt1, 2, and 3 with Ki values of 0.08, 2, and 2.6 nM, respectively. It preferentially inhibits the proliferation of human cancer cell lines with Akt pathway activation and various cell lines derived from hematologic malignancies with minimal effect on glucose homeostasis. Afuresertib demonstrates activity against multiple myeloma in both preclinical and clinical models.[Cayman Chemical]

Synthesis

1047644-62-1

1047645-82-8

The general procedure for the synthesis of N-((S)-1-amino-3-(3-fluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxamide as a hydrochloride salt was as follows: 5 mL of methyl tert-butyl ether (MTBE) was added to 213.9 mg (0.500 mmol) of the amorphous free base and the mixture was heated under magnetic The mixture was heated to 40 °C under magnetic stirring and maintained for 1 hour. Subsequently, a 1,4-dioxane solution of 4 M HCl was added in four additions (totaling 1 equiv, 125.1 μL). After the first addition of 0.25 equivalents of HCl solution, the mixture was heated to 42 °C and 1 mL of acetonitrile was added to completely dissolve the solid. After the remaining HCl solution was added, solid precipitation was observed. The slurry was stirred at 42°C for 4 hours, then held sequentially at 35°C, 30°C, and 25°C for 90 minutes each at a rate of 5°C per hour, and finally cooled slowly to 22°C overnight. The white solid was collected by filtration and dried under vacuum at 50 °C while slowly purged by passing nitrogen overnight. The yield of the resulting hydrochloride was 73.6% (0.3685 mmol, 170.90 mg). The product was confirmed to be HCl salt with stoichiometric ratio of 1:1 by ion chromatography analysis, and the powder X-ray diffraction (PXRD) pattern (Figure 1) showed it to be in the crystalline state, with the following characteristic diffraction peaks, and a melting point of 211 °C. The characteristic PXRD peaks (2θ values, with d-spacing in parentheses): 7.2° (12.20 ?) , 14.4° (6.16 ?) , 17.9° (4.94 ?) , 18.5° (4.79 ?) , 20.8° (4.26 ?) , 21.5° (4.12 ?) , 22.4° (3.96 ?) , 22.9° (3.88 ?) , 23.7° (3.75 ?) , 24.5° (3.63 ?) , 24.7° (3.61 ?) , 25.1° (4.12 ?) , 25.7° (3.46 ?) , 27.3° (3.26 ?) , 28.2° (3.16 ?) , 28.8° (3.10 ?) , 30.4° (2.94 ?) , 32.4° (2.76 ?) , 32.7° (2.73 ?) , 35.2° (2.55 ?) , 36.1° (2.48 ?) , 40.0° (2.25 ?) , 41.3° (2.18 ?) , 41.7° (2.16 ?) The Measuring instrument: Panaco X'Pert-Pro MPD diffractometer with Johansson monochromator (Cu Kα1 radiation, wavelength 1.540598 ?) and X'Celerator detector. Key test parameters: voltage 45 kV, current 40 mA, start angle 2.0° 2θ, end angle 52.0° 2θ, step size 0.02°, counting time per step 40.0 s, scanning speed 0.05°/sec. Incident beam configuration: 2° fixed anti-scattering slit, programmable divergence slit; diffraction beam configuration: 0.02 rad Soller slit, programmable anti-scattering slit. Samples were prepared on a silicon zero background sample holder.

in vivo

Mice bearing BT474 breast tumor xenografts are dosed orally with either vehicle or GSK2110183 at 10, 30 or 100 mg/kg daily for 21 days which result in 8, 37 and 61% TGI, respectively. Mice tolerated GSK2110183 well, with 1-3% body weight loss reported after 5 days of dosing which recover over the course of the study. Other tumor xenograft models which possess an activation of the Akt pathway are explored to further demonstrate compound efficacy. Mice treated with GSK2110183 at 10, 30 and 100 mg/kg result in 23, 37 and 97% TGI, respectively, of SKOV3 xenografts[2].

IC 50

Akt1: 0.08 nM (Ki); Akt2: 2 nM (Ki); Akt3: 2.6 nM (Ki); Akt1 E17K mutant: 0.2 nM (IC50); PKCη: 210 nM (IC50); PKC-βI: 430 nM (IC50); ROCK: 100 nM (IC50); PKCθ: 510 nM (IC50)

References

[1] Patent: US2010/197754, 2010, A1. Location in patent: Page/Page column 8-9
[2] Patent: WO2008/98104, 2008, A1. Location in patent: Page/Page column 191-192

GSK2110183B Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

GSK2110183B Suppliers

WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Country
China
ProdList
1077
Advantage
64
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Suzhou yacoo science co.,Ltd
Tel
0512-87182056 18013166090
Fax
0512-87182056
Email
lingling.qi@yacoo.com.cn
Country
China
ProdList
6295
Advantage
60
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Fax
025-68650336
Email
info@adooq.cn
Country
China
ProdList
2990
Advantage
60
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Shanghai YuanQi Biotechnology Co., Ltd.
Tel
+86-2332782371 +86-18120098618
Email
sales@adobechem.com
Country
China
ProdList
1250
Advantage
50
D&C Chemicals
Tel
+86-21-58447131
Fax
+86-21-61642470
Email
1724405207@qq.com
Country
China
ProdList
472
Advantage
55
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9248
Advantage
55
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Fax
021-65675885
Email
info@efebio.com
Country
China
ProdList
9803
Advantage
58
Guangzhou QiYun Biotechnology Co., Ltd.
Tel
020-61288194 61288195
Fax
020-61288700
Email
505721671@qq.com
Country
China
ProdList
3866
Advantage
58
Qingdao IniKem BioPharmaTech Co.,Ltd
Tel
0532-58268780 18561687109;
Fax
-
Email
sales@inikem.com
Country
China
ProdList
299
Advantage
55
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
ChengDu TongChuangYuan Pharmaceutical Co.Ltd
Tel
028-83379370 13880556291
Fax
028-87747383
Email
tcy@tcypharm.com
Country
China
ProdList
7218
Advantage
58
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
9125
Advantage
58
Amadis Chemical Company Limited
Tel
571-89925085
Fax
0086-571-89925065
Email
sales@amadischem.com
Country
China
ProdList
131957
Advantage
58
Chuzhou KeMail Chemical Technology Co., Ltd
Tel
0550-5196001 15000891977
Fax
0550-5196001
Email
wj520wjxby@126.com
Country
China
ProdList
1944
Advantage
55
Dezhou LonWel Pharmaceutical Technology Co., Ltd.
Tel
13761310616
Fax
QQ: 39324283
Email
39324283@qq.com
Country
China
ProdList
1628
Advantage
58
Jiaxing Deyi Chemical Co., Ltd.
Tel
86-0573-85866609 13325730825
Fax
0573-85866609
Email
945717149@qq.com
Country
China
ProdList
8595
Advantage
58
Twochem Co.Ltd.
Tel
021-58111628 15800915896
Fax
QQ 3285589261
Email
sales@twochem.com
Country
China
ProdList
1788
Advantage
58
Angel Pharmatech, Ltd.
Tel
17317130613
Fax
QQ3358272972
Email
3358272972@qq.com
Country
China
ProdList
3277
Advantage
58
Shanghai Jizhi Biochemical Technology Co. Ltd.
Tel
4009004166/18616739031 18616739031
Email
3007523370@qq.com
Country
China
ProdList
52687
Advantage
58
Shanghai Maruhua Science and Technology Co. Ltd.
Tel
021-57171708 18721745940
Fax
QQ1139783351
Email
sales@api-chem.com
Country
China
ProdList
1968
Advantage
58
Shanghai Hongye Biotechnology Co. Ltd
Tel
400-9205774
Email
sales@glpbio.cn
Country
China
ProdList
6777
Advantage
58
Shanghai Moss Medicine Technology Co., Ltd.
Tel
+86-188369842 +86-15618151133
Fax
QQ188369842
Email
188369842@qq.com
Country
China
ProdList
1959
Advantage
58
Fan De(Beijing) Biotechnology Co., Ltd.
Tel
15911056312
Email
liming@bio-fount.com
Country
China
ProdList
9729
Advantage
58
Tianjin Kaifu Pharmaceutical Technology Co., Ltd.
Tel
18081075745
Email
chemflowtech@sina.com
Country
China
ProdList
1886
Advantage
58
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471
Email
sales@sarms4muscle.com
Country
China
ProdList
10473
Advantage
58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel
86-571-88216897,88216896 13588875226
Fax
86-571-88216895
Email
sales@hzclap.com
Country
CHINA
ProdList
6312
Advantage
58
Changzhou Chenhong Biotechnology Co., Ltd.
Tel
+86-0519-85788828 +86-13775037613
Email
sales@chemrenpharm.com
Country
China
ProdList
3934
Advantage
58
Shanghai Zeye Biotechnology Co., Ltd.
Tel
021-021-61998551 13122364865
Email
sale1@shzysw.net
Country
China
ProdList
9778
Advantage
58
Absin Bioscience Inc.
Tel
021-38015121 18438616290
Email
lanwu@univ-bio.com
Country
China
ProdList
24731
Advantage
58
Shanghai hongqu biomedical technology co. LTD
Tel
88888888888
Email
hongquchem@qq.com
Country
China
ProdList
5132
Advantage
58
Shanghai Luofa Biochemical Technology Co., Ltd.
Tel
021-51111890 15317326293
Email
sales@molnova.com
Country
China
ProdList
4195
Advantage
58
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15727060112
Email
yutianchun2007@126.com
Country
China
ProdList
9814
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing1@energy-chemical.com
Country
China
ProdList
44894
Advantage
58
cjbscvictory
Tel
13348960310
Email
3003867561@qq.com
Country
China
ProdList
10503
Advantage
58
Abmole Bioscience Inc.
Tel
021-50967598 02150967598
Email
sales@abmole.cn
Country
China
ProdList
4494
Advantage
58
Jinan Jiuli Biotechnology Co. , Ltd.
Tel
15865264761
Email
486064515@qq.com
Country
China
ProdList
4809
Advantage
58
Jiangsu Nanchuang Chemical and Life Health Research Institute Co., Ltd.
Tel
15720605021
Fax
QQ:353175721
Email
zhang_lei@jsnchem.com
Country
China
ProdList
1810
Advantage
58
Hubei Kele Fine Chemical Co., Ltd
Tel
027-59101668 19945030958
Fax
027-59101668
Email
2881924765@qq.com
Country
China
ProdList
7936
Advantage
58
ChemeGen
Tel
18818260767
Fax
QQ 3610331285
Email
2625930290@qq.com
Country
China
ProdList
6973
Advantage
58
Shanghai Taopu Industrial Co., LTD
Tel
159-00573766 18018507602
Email
394643792@qq.com
Country
China
ProdList
4328
Advantage
58
Bide Pharmatech Ltd.
Tel
400-1647117 13681763483
Email
product02@bidepharm.com
Country
China
ProdList
59936
Advantage
58
InvivoChem
Tel
13549236410
Email
sales@invivochem.cn
Country
China
ProdList
6753
Advantage
58
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd
Tel
029-029-029-81148696 18161915376
Email
1040@dideu.com
Country
China
ProdList
10001
Advantage
58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.
Tel
15387063101
Email
2881924050@qq.com
Country
China
ProdList
9957
Advantage
58
Shandong Mingde Biotechnology Co., Ltd
Tel
15553348166
Email
m15553348166@163.com
Country
China
ProdList
9967
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
Shanghai Maclean Biochemical Technology Co., LTD
Tel
021-021-50706066 15221275939
Email
shenlinxing@macklin.cn
Country
China
ProdList
29784
Advantage
58

1047645-82-8, GSK2110183BRelated Search:


  • Afuresertib (hydrochloride)
  • GSK 2110183B
  • GSK2110183B
  • GSK-2110183B
  • GSK 2110183 hydrochloride
  • GSK2110183 hydrochloride
  • GSK-2110183 hydrochloride
  • N-((S)-1-Amino-3-(3-fluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxamide hydrochloride
  • Afuresertib HCl
  • Afuresertib HCl (GSK2110183)
  • Afuresertib HCl salt, GSK-2110183 HCl salt, GSK-2110183B HCl salt
  • N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
  • 2-Thiophenecarboxamide, n-[(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-, hydrochloride (1:1)
  • AFURESERTIB;GSK 2110183;GSK2110183;GSK 2110183 HYDROCHLORIDE; GSK2110183 HYDROCHLORIDE; GSK-2110183 HYDROCHLORIDE
  • GSK 2110183 hydrochloride - Afuresertib hydrochloride
  • (S)-N-(1-amino-3-(3-fluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)thiophene-2-carboxamide hydrochloride
  • Afuresertib hydrochloride GSK2110183
  • Afuresertib,PKC,Protein kinase C,Akt,PKB,Rho-kinase,GSK2110183,ROK,Rho-associated protein kinase,Inhibitor,GSK-2110183,inhibit,Protein kinase B,Afuresertib hydrochloride,Rho-associated kinase,GSK 2110183,ROCK
  • (S)-N-(1-amino-3- (3-fluorophenyl) propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl) thiophene-2-formamide, hydrochloride
  • Afuresertib hydrochloride, 10 mM in DMSO
  • N-[(2S)-1-amino-3-(3-fluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)thiophene-2-carboxamide
  • 1047645-82-8
  • C18H17Cl2FN4OSClH